APL is a distinct subtype of myeloid leukaemia that in almost 100% of cases is associated with chromosomal translocations involving the PML and retinoic acid receptor α (RARA) loci, leading to the ...
You have full access to this article via your institution. After diagnosis based on laboratory, immunophenotypic and morphologic findings, we started all-trans retinoic acid (ATRA) treatment first.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results